{"count": 5, "results": [{"_id": "36475227", "pmid": 36475227, "pmcid": "PMC9717522", "title": "Comparing Simvastatin Monotherapy V/S Simvastatin-Ezetimibe Combination Therapy for the Treatment of Hyperlipidemia: A Meta-Analysis and Review", "journal": "Cureus", "authors": ["Chauhan D", "Memon F", "Patwardhan V", "Kotwani P", "Shah P", "Samala Venkata V"], "date": "2022-11-02T00:00:00Z", "doi": "10.7759/cureus.31007", "meta_date_publication": "2022 Nov", "meta_volume": "14", "meta_issue": "11", "meta_pages": "e31007", "score": 50301.04, "text_hl": "Comparing @CHEMICAL_Simvastatin @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ Monotherapy V/S @<m>CHEMICAL_Ezetimibe_Simvastatin_Drug_Combination</m> @CHEMICAL_MESH:D000069499 @@@Simvastatin-Ezetimibe@@@ Combination Therapy for the Treatment of @<m>DISEASE_Hyperlipidemias</m> @DISEASE_MESH:D006949 @@@Hyperlipidemia@@@: A Meta-Analysis and Review", "citations": {"NLM": "Chauhan D, Memon F, Patwardhan V, Kotwani P, Shah P, Samala Venkata V. Comparing Simvastatin Monotherapy V/S Simvastatin-Ezetimibe Combination Therapy for the Treatment of Hyperlipidemia: A Meta-Analysis and Review Cureus. 2022 Nov;14(11):e31007. PMID: 36475227", "BibTeX": "@article{36475227, title={Comparing Simvastatin Monotherapy V/S Simvastatin-Ezetimibe Combination Therapy for the Treatment of Hyperlipidemia: A Meta-Analysis and Review}, author={Chauhan D and Memon F and Patwardhan V and Kotwani P and Shah P and Samala Venkata V}, journal={Cureus}, volume={14}, number={11}, pages={e31007}}"}}, {"_id": "20152243", "pmid": 20152243, "title": "Long-term safety and efficacy of triple combination ezetimibe/simvastatin plus extended-release niacin in patients with hyperlipidemia.", "journal": "Am J Cardiol", "authors": ["Fazio S", "Guyton JR", "Polis AB", "Adewale AJ", "Tomassini JE", "Ryan NW", "Tershakovec AM"], "date": "2010-02-15T00:00:00Z", "doi": "10.1016/j.amjcard.2009.10.001", "meta_date_publication": "2010 Feb 15", "meta_volume": "105", "meta_issue": "4", "meta_pages": "487-94", "score": 50083.59, "text_hl": "In conclusion, the combination of @<m>CHEMICAL_Ezetimibe_Simvastatin_Drug_Combination</m> @CHEMICAL_MESH:D000069499 @@@E/S@@@ plus @CHEMICAL_Niacin @CHEMICAL_MESH:D009525 @@@niacin@@@ was generally well tolerated, aside from @CHEMICAL_Niacin @CHEMICAL_MESH:D009525 @@@niacin@@@-associated @DISEASE_Flushing @DISEASE_MESH:D005483 @@@flushing@@@, and was significantly superior to @<m>CHEMICAL_Ezetimibe_Simvastatin_Drug_Combination</m> @CHEMICAL_MESH:D000069499 @@@E/S@@@ alone in improving several lipoprotein parameters during a 64-week trial in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Hyperlipidemias</m> @DISEASE_MESH:D006949 @@@hyperlipidemia@@@. ", "citations": {"NLM": "Fazio S, Guyton JR, Polis AB, Adewale AJ, Tomassini JE, Ryan NW, Tershakovec AM. Long-term safety and efficacy of triple combination ezetimibe/simvastatin plus extended-release niacin in patients with hyperlipidemia. Am J Cardiol. 2010 Feb 15;105(4):487-94. PMID: 20152243", "BibTeX": "@article{20152243, title={Long-term safety and efficacy of triple combination ezetimibe/simvastatin plus extended-release niacin in patients with hyperlipidemia.}, author={Fazio S and Guyton JR and Polis AB and Adewale AJ and Tomassini JE and Ryan NW and Tershakovec AM}, journal={Am J Cardiol}, volume={105}, number={4}, pages={487-94}}"}}, {"_id": "20496342", "pmid": 20496342, "title": "Drug Class Review: Fixed Dose Combination Drug Products for the Treatment of Type 2 Diabetes and Hyperlipidemia: Final Report", "journal": "", "authors": ["McDonagh M", "Peterson K", "Thakurta SG", "Dana T"], "date": "2007-10-01T00:00:00Z", "meta_date_publication": "2007 Oct", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50072.637, "text_hl": "Drug Class Review: Fixed Dose Combination Drug Products for the Treatment of @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@Type 2 Diabetes@@@ and @<m>DISEASE_Hyperlipidemias</m> @DISEASE_MESH:D006949 @@@Hyperlipidemia@@@: Final Report", "citations": {"NLM": "McDonagh M, Peterson K, Thakurta SG, Dana T. Drug Class Review: Fixed Dose Combination Drug Products for the Treatment of Type 2 Diabetes and Hyperlipidemia: Final Report . 2007 Oct;():. PMID: 20496342", "BibTeX": "@article{20496342, title={Drug Class Review: Fixed Dose Combination Drug Products for the Treatment of Type 2 Diabetes and Hyperlipidemia: Final Report}, author={McDonagh M and Peterson K and Thakurta SG and Dana T}}"}}, {"_id": "23926117", "pmid": 23926117, "pmcid": "PMC3828803", "title": "Changes in Lipoprotein Particle Number With Ezetimibe/Simvastatin Coadministered With Extended-Release Niacin in Hyperlipidemic Patients", "journal": "J Am Heart Assoc", "authors": ["Le NA", "Jin R", "Tomassini JE", "Tershakovec AM", "Neff DR", "Wilson PW"], "date": "2013-08-07T00:00:00Z", "doi": "10.1161/JAHA.113.000037", "meta_date_publication": "2013 Aug 7", "meta_volume": "2", "meta_issue": "4", "meta_pages": "e000037", "score": 50069.54, "text_hl": "In conclusion, @<m>CHEMICAL_Ezetimibe_Simvastatin_Drug_Combination</m> @CHEMICAL_MESH:D000069499 @@@E/S@@@+@CHEMICAL_Nitrogen @CHEMICAL_MESH:D009584 @@@N@@@ therapy reduced LDL-P and increased HDL-P more than @CHEMICAL_Nitrogen @CHEMICAL_MESH:D009584 @@@N@@@ or @<m>CHEMICAL_Ezetimibe_Simvastatin_Drug_Combination</m> @CHEMICAL_MESH:D000069499 @@@E/S@@@ monotherapy in @SPECIES_9606 @@@patients@@@ with mixed @<m>DISEASE_Hyperlipidemias</m> @DISEASE_MESH:D006949 @@@hyperlipidemia@@@. ", "citations": {"NLM": "Le NA, Jin R, Tomassini JE, Tershakovec AM, Neff DR, Wilson PW. Changes in Lipoprotein Particle Number With Ezetimibe/Simvastatin Coadministered With Extended-Release Niacin in Hyperlipidemic Patients J Am Heart Assoc. 2013 Aug 7;2(4):e000037. PMID: 23926117", "BibTeX": "@article{23926117, title={Changes in Lipoprotein Particle Number With Ezetimibe/Simvastatin Coadministered With Extended-Release Niacin in Hyperlipidemic Patients}, author={Le NA and Jin R and Tomassini JE and Tershakovec AM and Neff DR and Wilson PW}, journal={J Am Heart Assoc}, volume={2}, number={4}, pages={e000037}}"}}, {"_id": "18420099", "pmid": 18420099, "title": "Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia.", "journal": "J Am Coll Cardiol", "authors": ["Guyton JR", "Brown BG", "Fazio S", "Polis A", "Tomassini JE", "Tershakovec AM"], "date": "2008-04-22T00:00:00Z", "doi": "10.1016/j.jacc.2008.03.003", "meta_date_publication": "2008 Apr 22", "meta_volume": "51", "meta_issue": "16", "meta_pages": "1564-72", "score": 50067.15, "text_hl": "CONCLUSIONS: Combination treatment with @<m>CHEMICAL_Ezetimibe_Simvastatin_Drug_Combination</m> @CHEMICAL_MESH:D000069499 @@@E/S@@@ plus @CHEMICAL_Nitrogen @CHEMICAL_MESH:D009584 @@@N@@@ showed superior @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@-altering efficacy compared with @CHEMICAL_Nitrogen @CHEMICAL_MESH:D009584 @@@N@@@ or @<m>CHEMICAL_Ezetimibe_Simvastatin_Drug_Combination</m> @CHEMICAL_MESH:D000069499 @@@E/S@@@ in @<m>DISEASE_Hyperlipidemias</m> @DISEASE_MESH:D006949 @@@type IIa or IIb hyperlipidemia@@@ @SPECIES_9606 @@@patients@@@ and was generally well tolerated aside from @CHEMICAL_Nitrogen @CHEMICAL_MESH:D009584 @@@N@@@-associated @DISEASE_Flushing @DISEASE_MESH:D005483 @@@flushing@@@. ", "citations": {"NLM": "Guyton JR, Brown BG, Fazio S, Polis A, Tomassini JE, Tershakovec AM. Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia. J Am Coll Cardiol. 2008 Apr 22;51(16):1564-72. PMID: 18420099", "BibTeX": "@article{18420099, title={Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia.}, author={Guyton JR and Brown BG and Fazio S and Polis A and Tomassini JE and Tershakovec AM}, journal={J Am Coll Cardiol}, volume={51}, number={16}, pages={1564-72}}"}}]}